JABIL INC.

(JBL)
  Report
Delayed Nyse  -  05/19 04:00:02 pm EDT
57.57 USD   -1.40%
05/18Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Reusable Drug Delivery Device with Broad Applicability
BU
05/17Jabil Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material and Digital Manufacturing Expansions
BU
05/17Jabil Inc. Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material and Digital Manufacturing Expansions
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

JABIL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)

01/07/2022 | 08:21am EDT

Overview

We are one of the leading providers of worldwide manufacturing services and
solutions. We provide comprehensive electronics design, production and product
management services to companies in various industries and end markets. Our
services enable our customers to reduce manufacturing costs, improve
supply-chain management, reduce inventory obsolescence, lower transportation
costs and reduce product fulfillment time. Our manufacturing and supply chain
management services and solutions include innovation, design, planning,
fabrication and assembly, delivery and managing the flow of resources and
products. We derive substantially all of our revenue from production and product
management services (collectively referred to as "manufacturing services"),
which encompass the act of producing tangible components that are built to
customer specifications and are then provided to the customer.
We serve our customers primarily through dedicated business units that combine
highly automated, continuous flow manufacturing with advanced electronic design
and design for manufacturability. We currently depend, and expect to continue to
depend for the foreseeable future, upon a relatively small number of customers
for a significant percentage of our net revenue, which in turn depends upon
their growth, viability and financial stability.
We conduct our operations in facilities that are located worldwide, including
but not limited to, China, Ireland, Malaysia, Mexico, Singapore and the United
States. We derived a substantial majority, 84.8% of net revenue, from our
international operations for the three months ended November 30, 2021. Our
global manufacturing production sites allow customers to manufacture products
simultaneously in the optimal locations for their products. Our global presence
is key to assessing and executing on our business opportunities.
We have two reporting segments: Electronics Manufacturing Services ("EMS") and
Diversified Manufacturing Services ("DMS"), which are organized based on the
economic profiles of the services performed, including manufacturing
capabilities, market strategy, margins, return on capital and risk profiles. Our
EMS segment is focused around leveraging IT, supply chain design and
engineering, technologies largely centered on core electronics, utilizing our
large scale manufacturing infrastructure and our ability to serve a broad range
of end markets. Our EMS segment is a high volume business that produces product
at a quicker rate (i.e. cycle time) and in larger quantities and includes
customers primarily in the 5G, wireless and cloud, digital print and retail,
industrial and semi-cap, and networking and storage industries. Our DMS segment
is focused on providing engineering solutions, with an emphasis on material
sciences, technologies and healthcare. Our DMS segment includes customers
primarily in the automotive and transportation, connected devices, healthcare
and packaging, and mobility industries.
We monitor the current economic environment and its potential impact on both the
customers we serve as well as our end-markets and closely manage our costs and
capital resources so that we can respond appropriately as circumstances change.
Refer to Item 7. "Management's Discussion and Analysis of Financial Condition
and Results of Operations" section contained in our Annual Report on Form 10-K
for the fiscal year ended August 31, 2021 for further discussion of the items
disclosed in Item 2. "Management's Discussion and Analysis of Financial
Condition and Results of Operations" section as of November 30, 2021 contained
herein.
COVID-19
The COVID-19 pandemic, which began to impact us in January 2020, has continued
to affect our business and the businesses of our customers and suppliers. Travel
and business operation restrictions arising from virus containment efforts of
governments around the world have continued to impact our operations in Asia,
Europe and the Americas. Essential activity exceptions from these restrictions
have allowed us to continue to operate but virus containment efforts have
resulted in additional direct costs.
The impact on our suppliers has led to supply chain constraints, including
difficulty sourcing materials necessary to fulfill customer production
requirements and challenges in transporting completed products to our end
customers.
Summary of Results
The following table sets forth, for the periods indicated, certain key operating
results and other financial information (in millions, except per share data):
                                       17

--------------------------------------------------------------------------------

  Table of Contents
                                                                             Three months ended
                                                                                 November 30, 2021           November 30, 2020
Net revenue                                                                    $            8,567          $            7,833
Gross profit                                                                   $              675          $              635
Operating income                                                               $              350          $              314
Net income attributable to Jabil Inc.                                          $              241          $              200
Earnings per share-basic                                                       $             1.68          $             1.33
Earnings per share-diluted                                                     $             1.63          $             1.31


Key Performance Indicators
Management regularly reviews financial and non-financial performance indicators
to assess the Company's operating results. Changes in our operating assets and
liabilities are largely affected by our working capital requirements, which are
dependent on the effective management of our sales cycle as well as timing of
payments. Our sales cycle measures how quickly we can convert our manufacturing
services into cash through sales. We believe the metrics set forth below are
useful to investors in measuring our liquidity as future liquidity needs will
depend on fluctuations in levels of inventory, accounts receivable and accounts
payable.
The following table sets forth, for the quarterly periods indicated, certain of
management's key financial performance indicators:
                                                                                          Three months ended
                                                           November 30, 2021                 August 31, 2021              November 30, 2020
Sales cycle(1)                                                           22 days                         19 days                        16 days
Inventory turns (annualized)(2)                                          5 turns                         5 turns                        7 turns
Days in accounts receivable(3)                                           41 days                         38 days                        42 days
Days in inventory(4)                                                     66 days                         71 days                        55 days
Days in accounts payable(5)                                              85 days                         90 days                        80 days




(1)The sales cycle is calculated as the sum of days in accounts receivable and
days in inventory, less the days in accounts payable; accordingly, the variance
in the sales cycle quarter over quarter was a direct result of changes in these
indicators.
(2)Inventory turns (annualized) are calculated as 360 days divided by days in
inventory.
(3)Days in accounts receivable is calculated as accounts receivable, net,
divided by net revenue multiplied by 90 days. During the three months ended
November 30, 2021, the increase in days in accounts receivable from the prior
sequential quarter was primarily due to an increase in accounts receivable,
primarily driven by higher sales and timing of collections.
(4)Days in inventory is calculated as inventory and contract assets divided by
cost of revenue multiplied by 90 days. During the three months ended November
30, 2021, the decrease in days in inventory from the prior sequential quarter
was due to increased sales activity during the quarter. During the three months
ended November 30, 2021, the increase in days in inventory from the three months
ended November 30, 2020 was primarily due to supply chain constraints and
increased materials purchases to support expected sales levels in the second
quarter of fiscal year 2022.
(5)Days in accounts payable is calculated as accounts payable divided by cost of
revenue multiplied by 90 days. During the three months ended November 30, 2021,
the decrease in days in accounts payable from the prior sequential quarter was
primarily due to timing of purchases and cash payments during the quarter.
During the three months ended November 30, 2021, the increase in days in
accounts payable from the three months ended November 30, 2020 was primarily due
to an increase for material purchases and the timing of payments.
Critical Accounting Policies and Estimates
The preparation of our Condensed Consolidated Financial Statements and related
disclosures in conformity with U.S. generally accepted accounting principles
("U.S. GAAP") requires management to make estimates and judgments that affect
our reported amounts of assets and liabilities, revenues and expenses, and
related disclosures of contingent assets and liabilities. On an on-going basis,
we evaluate our estimates and assumptions based upon historical experience and
various other factors and circumstances. Management believes that our estimates
and assumptions are reasonable under the circumstances; however, actual results
may vary from these estimates and assumptions under different future
circumstances. For further discussion of our
                                       18
--------------------------------------------------------------------------------
  Table of Contents
significant accounting policies, refer to Note 1 - "Description of Business and
Summary of Significant Accounting Policies" to the Consolidated Financial
Statements and "Management's Discussion and Analysis of Financial Condition and
Results of Operations - Critical Accounting Policies and Estimates" in our
Annual Report on Form 10-K for the fiscal year ended August 31, 2021.
Recent Accounting Pronouncements
See Note 17 - "New Accounting Guidance" to the Condensed Consolidated Financial
Statements for a discussion of recent accounting guidance.
Results of Operations
Net Revenue
Generally, we assess revenue on a global customer basis regardless of whether
the growth is associated with organic growth or as a result of an acquisition.
Accordingly, we do not differentiate or separately report revenue increases
generated by acquisitions as opposed to existing business. In addition, the
added cost structures associated with our acquisitions have historically been
relatively insignificant when compared to our overall cost structure.
The distribution of revenue across our segments has fluctuated, and will
continue to fluctuate, as a result of numerous factors, including the following:
fluctuations in customer demand; efforts to diversify certain portions of our
business; business growth from new and existing customers; specific product
performance; and any potential termination, or substantial winding down, of
significant customer relationships.
                                             Three months ended
(dollars in millions)                                 November 30, 2021       November 30, 2020       Change

Net revenue                                          $            8,567      $            7,833        9.4  %




Net revenue increased during the three months ended November 30, 2021, compared
to the three months ended November 30, 2020. Specifically, the DMS segment net
revenue increased 11% due to: (i) a 6% increase in revenues from existing
customers within our mobility business, (ii) a 4% increase in revenues from
existing customers in our automotive and transportation business, and (iii) a 3%
increase in revenue from existing customers within our healthcare and packaging
business. The increase is partially offset by a 2% decrease in revenues from
existing customers within our connected devices business. The EMS segment net
revenue increased 7% due to: (i) a 4% increase from existing customers within
our industrial and capital equipment business, (ii) a 4% increase from existing
customers within our 5G, wireless and cloud business, and (iii) a 2% increase
from existing customers within our digital print and retail business. The
increase is partially offset by a 3% decrease from existing customers within our
networking and storage business.
The following table sets forth, for the periods indicated, revenue by segment
expressed as a percentage of net revenue:
                          Three months ended
                                      November 30, 2021      November 30, 2020
EMS                                                45  %                  46  %
DMS                                                55  %                  54  %
Total                                             100  %                 100  %

The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:

                                             Three months ended
                                                         November 30, 2021      November 30, 2020
Foreign source revenue                                              84.8  %                83.6  %


Gross Profit
                                       19

--------------------------------------------------------------------------------

  Table of Contents
                                               Three months ended
(dollars in millions)                                   November 30, 2021       November 30, 2020
Gross profit                                           $           675         $           635
Percent of net revenue                                             7.9    %                8.1    %


Gross profit as a percentage of net revenue decreased for the three months ended
November 30, 2021 compared to the three months ended November 30, 2020,
primarily due to product mix for the DMS segment.
Selling, General and Administrative
                                                                 Three months ended
(dollars in millions)                                                November 30, 2021           November 30, 2020             Change
Selling, general and administrative                                $              308          $              303          $          5


Selling, general and administrative expenses remained relatively consistent
during the three months ended November 30, 2021, compared to the three months
ended November 30, 2020.
Research and Development
                                                  Three months ended
(dollars in millions)                                        November 30, 2021        November 30, 2020
Research and development                                   $            9           $            8
Percent of net revenue                                                0.1      %               0.1      %


Research and development expenses remained relatively consistent as a percentage
of net revenue during the three months ended November 30, 2021, compared to the
three months ended November 30, 2020.
Amortization of Intangibles
                                                                           Three months ended
(dollars in millions)                                                           November 30, 2021           November 30, 2020             Change
Amortization of intangibles                                                   $                8          $               11          $         (3)

Amortization of intangibles remained relatively consistent during the three months ended November 30, 2021, compared to the three months ended November 30, 2020.

Restructuring, Severance and Related Charges

                                                                   Three months ended
(dollars in millions)                                                   November 30, 2021           November 30, 2020             Change
Restructuring, severance and related charges                          $                -          $               (1)         $          1


Restructuring, severance and related charges remained relatively consistent
during the three months ended November 30, 2021, compared to the three months
ended November 30, 2020. The 2021 Restructuring Plan was complete as of August
31, 2021.
Other Expense (Income)
                                                Three months ended
(dollars in millions)                                      November 30, 2021       November 30, 2020       Change
Other expense (income)                                    $                1      $               (1)     $    2

Other expense (income) remained relatively consistent during the three months ended November 30, 2021 compared to the three months ended November 30, 2020.

                                       20
--------------------------------------------------------------------------------
  Table of Contents
Interest Income
                                               Three months ended
(dollars in millions)                                     November 30, 2021       November 30, 2020       Change
Interest income                                          $                1      $                2      $    (1)


Interest income remained relatively consistent during the three months ended
November 30, 2021, compared to the three months ended November 30, 2020.
Interest Expense
                                               Three months ended
(dollars in millions)                                    November 30, 2021       November 30, 2020       Change
Interest expense                                        $               33      $               32      $    1


Interest expense remained relatively consistent during the three months ended
November 30, 2021, compared to the three months ended November 30, 2020.
Income Tax Expense
                                                              Three months ended
                                                                    November 30, 2021          November 30, 2020               Change
Effective income tax rate                                                       23.9  %                    29.6  %                  (5.7) %


The effective income tax rate decreased for the three months ended November 30,
2021, compared to the three months ended November 30, 2020, primarily due to
decreased losses in tax jurisdictions with existing valuation allowances for the
three months ended November 30, 2021.
Non-GAAP (Core) Financial Measures
The following discussion and analysis of our financial condition and results of
operations include certain non-GAAP financial measures as identified in the
reconciliations below. The non-GAAP financial measures disclosed herein do not
have standard meaning and may vary from the non-GAAP financial measures used by
other companies or how we may calculate those measures in other instances from
time to time. Non-GAAP financial measures should not be considered a substitute
for, or superior to, measures of financial performance prepared in accordance
with U.S. GAAP. Among other uses, management uses non-GAAP "core" financial
measures to make operating decisions, assess business performance and as a
factor in determining certain employee performance when evaluating incentive
compensation. Also, our "core" financial measures should not be construed as an
indication by us that our future results will be unaffected by those items that
are excluded from our "core" financial measures.
We determine the tax effect of the items excluded from "core" earnings and
"core" diluted earnings per share based upon evaluation of the statutory tax
treatment and the applicable tax rate of the jurisdiction in which the pre-tax
items were incurred, and for which realization of the resulting tax benefit, if
any, is expected. In certain jurisdictions where we do not expect to realize a
tax benefit (due to existing tax incentives or a history of operating losses or
other factors resulting in a valuation allowance related to deferred tax
assets), a reduced or 0% tax rate is applied.
Included in the tables below are reconciliations of the non-GAAP financial
measures to the most directly comparable U.S. GAAP financial measures as
provided in our Condensed Consolidated Financial Statements:
                                       21
--------------------------------------------------------------------------------
  Table of Contents
Reconciliation of U.S. GAAP Financial Results to Non-GAAP Measures
                                                                              Three months ended
(in millions, except for per share data)                                          November 30, 2021           November 30, 2020
Operating income (U.S. GAAP)                                                    $              350          $              314
Amortization of intangibles                                                                      8                          11
Stock-based compensation expense and related charges                                            35                          34
Restructuring, severance and related charges                                                     -                          (1)

Net periodic benefit cost (1)                                                                    7                           5

Acquisition and integration charges (2)                                                          -                           2
Adjustments to operating income                                                                 50                          51
Core operating income (Non-GAAP)                                                $              400          $              365
Net income attributable to Jabil Inc. (U.S. GAAP)                               $              241          $              200
Adjustments to operating income                                                                 50                          51

Net periodic benefit cost (1)                                                                   (7)                         (5)
Adjustments for taxes                                                                            -                          (1)
Core earnings (Non-GAAP)                                                        $              284          $              245

Diluted earnings per share (U.S. GAAP)                                          $             1.63          $             1.31

Diluted core earnings per share (Non-GAAP)                                      $             1.92          $             1.60

Diluted weighted average shares outstanding (U.S. GAAP and
Non-GAAP)                                                                                    147.7                       152.9




(1)We are reclassifying the pension components in other expense to core
operating income as we assess operating performance, inclusive of all components
of net periodic benefit cost, with the related revenue. There is no impact to
core earnings or diluted core earnings per share for this adjustment.
(2)Charges related to our strategic collaboration with Johnson & Johnson Medical
Devices Companies ("JJMD").
Adjusted Free Cash Flow
                                                                                Three months ended
 (in millions)                                                     November 30, 2021           November 30, 2020

Net cash (used in) provided by operating activities (U.S. GAAP) $ (46)

              $               65

Acquisition of property, plant and equipment                              (281)                            (353)

Proceeds and advances from sale of property, plant and equipment 208

                              111
Adjusted free cash flow (Non-GAAP)                               $        (119)              $             (177)


Liquidity and Capital Resources
We believe that our level of liquidity sources, which includes available
borrowings under our revolving credit facilities and commercial paper program,
additional proceeds available under our global asset-backed securitization
program and under our uncommitted trade accounts receivable sale programs, cash
on hand, cash flows provided by operating activities and access to the capital
markets, will be adequate to fund our cash requirements, including capital
expenditures, the payment of any declared quarterly dividends, any share
repurchases under the approved program, any potential acquisitions and our
working capital requirements for the next 12 months and beyond. We continue to
assess our capital structure and evaluate the merits of redeploying available
cash.
Cash and Cash Equivalents
As of November 30, 2021, we had approximately $1.2 billion in cash and cash
equivalents, of which a significant portion was held by our foreign
subsidiaries. Most of our foreign cash and cash equivalents as of November 30,
2021 could be repatriated to the United States without potential tax expense.
Notes Payable and Credit Facilities
Following is a summary of principal debt payments and debt issuance for our
notes payable and credit facilities:
                                       22

--------------------------------------------------------------------------------

  Table of Contents
                                                                                                                                                                         Borrowings                                       Total notes
                                                                                                                                                                           under                                            payable
                                                4.700%                4.900%                3.950%                                                                       revolving                  Borrowings                and
                                                Senior                Senior                Senior               3.600%             3.000%             1.700%              credit                      under                credit
(in millions)                                    Notes                 Notes                 Notes            Senior Notes       Senior Notes       Senior Notes       facilities (1)                  loans              facilities
Balance as of August 31, 2021               $        499          $        300          $        496          $     495          $     591          $     496          $         -                $          1          $      2,878
Borrowings                                             -                     -                     -                  -                  -                  -                  550                           -                   550
Payments                                               -                     -                     -                  -                  -                  -                 (550)                          -                  (550)
Other                                                  1                     -                     -                  -                  -                  -                    -                           -                     1
Balance as of November 30, 2021             $        500          $        300          $        496          $     495          $     591          $     496          $         -                $          1          $      2,879
                                                                                                                                                                       Jan 22, 2024
                                                                                                                                                                       and Jan 22,
Maturity Date                               Sep 15, 2022          Jul 14, 2023          Jan 12, 2028          Jan 15, 2030       Jan 15, 2031       Apr 15, 2026       2026                       Jul 31, 2026
Original Facility/                                                                                                                                                          $3.8
Maximum Capacity                             $500 million          $300
million          $500 million         $500 million       $600 million       $500 million         billion(1)                 $2 million




(1)As of November 30, 2021, we had $3.8 billion in available unused borrowing
capacity under our revolving credit facilities. The senior unsecured credit
agreement dated as of January 22, 2020 and amended on April 28, 2021 (the
"Credit Facility") acts as the back-up facility for commercial paper
outstanding, if any. We have a borrowing capacity of up to $1.8 billion under
our commercial paper program. Borrowings with an original maturity of 90 days or
less are recorded net within the statement of cash flows, and have been excluded
from the table above.
We have a shelf registration statement with the SEC registering the potential
sale of an indeterminate amount of debt and equity securities in the future to
augment our liquidity and capital resources.
Our Senior Notes and our credit facilities contain various financial and
nonfinancial covenants. A violation of these covenants could negatively impact
our liquidity by restricting our ability to borrow under the notes payable and
credit facilities and potentially causing acceleration of amounts due under
these notes payable and credit facilities. As of November 30, 2021 and August
31, 2021, we were in compliance with our debt covenants. Refer to Note 5 -
"Notes Payable and Long-Term Debt" to the Condensed Consolidated Financial
Statements for further details.
Global Asset-Backed Securitization Program
Certain Jabil entities participating in the global asset-backed securitization
program continuously sell designated pools of trade accounts receivable to a
special purpose entity, which in turn sells certain of the receivables at a
discount to conduits administered by an unaffiliated financial institution on a
monthly basis. In addition, a foreign entity participating in the global
asset-backed securitization program sells certain receivables at a discount to
conduits administered by an unaffiliated financial institution on a daily basis.
We continue servicing the receivables sold and in exchange receive a servicing
fee under the global asset-backed securitization program. Servicing fees related
to the asset-backed securitization programs recognized during the three months
ended November 30, 2021 and 2020 were not material. We do not record a servicing
asset or liability on the Condensed Consolidated Balance Sheets as we estimate
that the fee we receive to service these receivables approximates the fair
market compensation to provide the servicing activities.
The special purpose entity in the global asset-backed securitization program is
a wholly-owned subsidiary of the Company and is included in our Condensed
Consolidated Financial Statements. Certain unsold receivables covering up to the
maximum amount of net cash proceeds available under the domestic, or U.S.,
portion of the global asset-backed securitization program are pledged as
collateral to the unaffiliated financial institution as of November 30, 2021.
The global asset-backed securitization program expires on November 25, 2024 and
the maximum amount of net cash proceeds available at any one time is
$600 million. During the three months ended November 30, 2021, we sold
$1.0 billion of trade accounts receivable and we received cash proceeds of
$1.0 billion. As of November 30, 2021, we had no available liquidity under our
global asset-backed securitization program.


The global asset-backed securitization program requires compliance with several
covenants including compliance with the interest ratio and debt to EBITDA ratio
of the Credit Facility. As of November 30, 2021 and August 31, 2021, we were in
compliance with all covenants under our global asset-backed securitization
program. Refer to Note 6 - "Asset-Backed Securitization Program" to the
Condensed Consolidated Financial Statements for further details on the program.
                                       23
--------------------------------------------------------------------------------
  Table of Contents
Trade Accounts Receivable Sale Programs
As of November 30, 2021, we may elect to sell receivables and the unaffiliated
financial institution may elect to purchase specific accounts receivable at any
one time up to a: (i) maximum aggregate amount available of $2.0 billion under
nine trade accounts receivable sale programs, (ii) maximum amount available of
400 million CNY under one trade accounts receivable sale program and (iii)
maximum amount available of 100 million CHF under one trade accounts receivable
sale program. The trade accounts receivable sale programs expire on various
dates through 2025.


During the three months ended November 30, 2021, we sold $2.0 billion of trade
accounts receivable under these programs and we received cash proceeds of
$2.0 billion. As of November 30, 2021, we had up to $1.4 billion in available
liquidity under our trade accounts receivable sale programs.
Capital Expenditures
For Fiscal Year 2022, we anticipate our net capital expenditures will be
approximately $830 million. In general, our capital expenditures support ongoing
maintenance in our DMS and EMS segments and investments in capabilities and
targeted end markets. The amount of actual capital expenditures may be affected
by general economic, financial, competitive, legislative and regulatory factors,
among other things.
Cash Flows
The following table sets forth selected consolidated cash flow information (in
millions):
                                                                                   Three months ended
                                                                      November 30, 2021           November 30, 2020
Net cash (used in) provided by operating activities                 $         (46)              $               65
Net cash used in investing activities                                         (73)                            (264)
Net cash used in financing activities                                        (208)                             (87)
Effect of exchange rate changes on cash and cash equivalents                  (11)                               -
Net decrease in cash and cash equivalents                           $        (338)              $             (286)


Operating Activities
Net cash used in operating activities during the three months ended November 30,
2021 was primarily due to an increase in accounts receivable, inventories,
contract assets, prepaid expenses and other current assets; partially offset by:
an increase in accounts payable, accrued expenses and other liabilities,
non-cash expenses and net income. The increase in accounts receivable is
primarily driven by higher sales and the timing of collections. The increase in
inventories is primarily due to supply chain constraints and higher materials
purchases to support expected sales levels in the second quarter of fiscal year
2022. The increase in contract assets is primarily due to timing of revenue
recognition for over time customers. The increase in prepaid expenses and other
current assets is primarily due to the timing of payments. The increase in
accounts payable, accrued expenses and other liabilities is primarily due to the
timing of purchases and cash payments.
Investing Activities
Net cash used in investing activities during the three months ended November 30,
2021 consisted primarily of capital expenditures, principally to support ongoing
business in the DMS and EMS segments, partially offset by proceeds and advances
from the sale of property, plant and equipment.
Financing Activities
Net cash used in financing activities during the three months ended November 30,
2021 was primarily due to (i) payments for debt agreements, (ii) the repurchase
of our common stock under our share repurchase authorization, (iii) the purchase
of treasury stock under employee stock plans and (iv) dividend payments. Net
cash used in financing activities was partially offset by borrowings under debt
agreements.
Contractual Obligations
                                       24
--------------------------------------------------------------------------------
  Table of Contents
As of the date of this report, other than the new operating and finance leases,
(see Note 4 - "Leases" to the Condensed Consolidated Financial Statements),
there were no material changes outside the ordinary course of business, since
August 31, 2021 to our contractual obligations and commitments and the related
cash requirements.
Dividends and Share Repurchases
We currently expect to continue to declare and pay regular quarterly dividends
of an amount similar to our past declarations. However, the declaration and
payment of future dividends are discretionary and will be subject to
determination by our Board of Directors each quarter following its review of our
financial performance and global economic conditions.
In July 2021, the Board of Directors approved an authorization for the
repurchase of up to $1.0 billion of our common stock (the "2022 Share Repurchase
Program"). As of November 30, 2021, 2.8 million shares had been repurchased for
$169 million and $831 million remains available under the 2022 Share Repurchase
Program.
Item 3.     Quantitative and Qualitative Disclosures About Market Risk


There have been no material changes in our primary risk exposures or management
of market risks from those disclosed in our Annual Report on Form 10-K for the
fiscal year ended August 31, 2021.
Item 4.     Controls and Procedures


Evaluation of Disclosure Controls and Procedures
We carried out an evaluation required by Rules 13a-15 and 15d-15 under the
Exchange Act (the "Evaluation"), under the supervision and with the
participation of our Chief Executive Officer ("CEO") and Chief Financial Officer
("CFO"), of the effectiveness of our disclosure controls and procedures as
defined in Rules 13a-15 and 15d-15 under the Exchange Act as of November 30,
2021. Based on the Evaluation, our CEO and CFO concluded that the design and
operation of our disclosure controls were effective to ensure that information
required to be disclosed by us in reports that we file or submit under the
Exchange Act is (i) recorded, processed, summarized and reported within the time
periods specified in SEC rules and forms, and (ii) accumulated and communicated
to our senior management, including our CEO and CFO, to allow timely decisions
regarding required disclosure.
Changes in Internal Control over Financial Reporting
For our fiscal quarter ended November 30, 2021, we did not identify any
modifications to our internal control over financial reporting that have
materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.

                                       25

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses

All news about JABIL INC.
05/18Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Re..
BU
05/17Jabil Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material..
BU
05/17Jabil Inc. Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Mat..
CI
05/13JABIL INC. : Ex-dividend day for
FA
05/04JABIL INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements..
AQ
04/27Jabil, Ams OSRAM Develop Lateral Flow Testing Platform
MT
04/27Jabil and ams OSRAM Enable Innovative Lateral Flow Testing Platform
BU
04/27Jabil and ams OSRAM Enable Innovative Lateral Flow Testing Platform
CI
04/21Jabil Keeps Quarterly Dividend at $0.08 a Share, Payable June 2 to Shareholders as of M..
MT
04/21Jabil Declares Quarterly Dividend
BU
More news
Analyst Recommendations on JABIL INC.
More recommendations